Aider is a “pair-programming” tool that can use various providers as the AI back end, including a locally running instance of ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Show your support for global excellence and gain visibility with top leaders. See the projects that earned top honors. Celebrating the most innovative and impactful construction projects worldwide.

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

There are some key clinical and financial use cases already showing their worth – but while innovation around artificial intelligence is happening rapidly, there's risk in moving too quickly, one ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

The University of Kansas Health System has boosted overall block utilization by 20% total, prime time by almost 5% total and overall volume by 8% – all with a 7% reduction in available room.

The vulnerabilities may have been exploited in 'an extremely sophisticated attack against specific targeted individuals' using versions of iOS prior to iOS 26, as per Apple's security bulletin.